Evaluate the Safety and Pharmacokinetic Profile of ETR028 and ETR029 in Healthy Adult Subjects
Clinical trial NCT05572190 · UNKNOWN
Trial details
- NCT number
- NCT05572190
- Sponsor
- Elysium Therapeutics, Inc.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-27
- Primary completion
- 2024-03-20
- Enrollment
- 78
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.